41
Aditia Retno Fitri Department of Pharmacology Faculty of Medicine Diponegoro University Indonesia

Hematinic I ARF: Iron

Embed Size (px)

Citation preview

Page 1: Hematinic I ARF: Iron

Aditia Retno FitriDepartment of PharmacologyFaculty of Medicine Diponegoro UniversityIndonesia

Page 2: Hematinic I ARF: Iron

Overview Hematinic Agents

Iron Folic Acid and Vitamine B12

Haemopoetic Growth Factors

Page 3: Hematinic I ARF: Iron
Page 4: Hematinic I ARF: Iron

http://www.theironfiles.co.uk/Sickle-cell/General/SCDBlood.html

Page 5: Hematinic I ARF: Iron

http://www.theironfiles.co.uk/Sickle-cell/General/SCDBlood.html

Page 6: Hematinic I ARF: Iron

4 globin + 1 haem. Haem

consists of a tetrapyrrole porphyrin ring containing ferrous (Fe2+) iron.

Each haem group can carry 1 oxygen molecule bound reversibly to Fe2+ and to a

histidine residue in the globin chain basis of oxygen transport.

Page 7: Hematinic I ARF: Iron

Definition: ↓ [Hb] in blood &/ RBC per age, sex and geographical location.

Normal Hb: 14g to 16g /dl in Male 13g to 15g /dl in Female

Acute: fatigue chronic: asymptomatic. Classification based on indices of red cell are:

hypochromic, microcytic anaemia macrocytic anaemia normochromic normocytic anaemia mixed pictures.

Page 8: Hematinic I ARF: Iron
Page 9: Hematinic I ARF: Iron

BALANCE

OUTPUT

MACHINE

INPUT

Page 10: Hematinic I ARF: Iron

<<<< INPUT:Nutritional deficiency

IMBALANCE

BROKEN MACHINE- - Synthesis <<- - Chronic disease

>>>OUTPUT: Bleeding Haemolysis

Page 11: Hematinic I ARF: Iron

<<<< INPUT:Nutritional deficiency

IMBALANCE

BROKEN MACHINE- - Synthesis <<- - Chronic disease

>>>OUTPUT: Bleeding Haemolysis

FIX THE UNDERLYING CAUSES!!

Page 12: Hematinic I ARF: Iron

↓↓↓↓ FORMATION

1. Nutritional Iron Deficiency

Folic Acid/ Vit B12 Deficiency

Protein Deficiency 2. Decreased Synthesis

Aplastic Anaemia Replacement of BM (e.g.

Leukaemia) Thalassaemia

3. Chronic Disorder Kidney Disease Advanced Malignancy Chronic Liver Disease

↑↑ ↑↑DESTRUCTION

1. Post Haemorrhage Acute & chronicBlood Loss

2. Excessive Haemolysis Intracellular Defect

(Defective RBC)▪ Thalassaemia▪ Haemoglobinopathies▪ Sickle Cell Anaemia

Extracellular Defect▪ Rh Incompatibility▪ Auto Immune Haemolytic

Anaemia▪ Certain Snake Venom

Page 13: Hematinic I ARF: Iron
Page 14: Hematinic I ARF: Iron

Hematinics are drugs used to stimulate the formation of red blood cells.

Used primarily in the treatment of anemia Example:

Iron Folic Acid Vitamin B12

Page 15: Hematinic I ARF: Iron
Page 16: Hematinic I ARF: Iron

Basic Pharmacology Pharmacokinetic

Absorption Pharmacodynamic Indication Drug Interaction Side Effect

Page 17: Hematinic I ARF: Iron

Important properties : several oxidation states form stable coordination complexes

Fe + protoporfirin Heme Heme + globin Hemoglobin Hemoglobin binds O2 & provides O2 delivery Fe deficiency microcytic hypochromic anemia Body content of iron:

Essential: myoglobin, Hb, enzym, transferrin not available for haemoglobin synthesis

Storage: Ferritin, hemosiderin Hb synthesis

Page 18: Hematinic I ARF: Iron
Page 19: Hematinic I ARF: Iron
Page 20: Hematinic I ARF: Iron

PHARMACOKINETICS

Page 21: Hematinic I ARF: Iron

Daily diet : 10–15 mg absorbption 5–10% Location : duodenum and proximal jejunum Heme iron directly absorbed Nonheme iron reduced to ferrous (Fe 2+) absorbed Iron crosses the luminal membrane by active transport of ferrous

iron and absorption of iron complexed with heme DMT1 transporter absorbed iron can be actively transported into the blood by

ferroportin and oxidized to ferric iron (Fe3+) Excess iron can be stored in intestinal epithelial cells as ferritin

Page 22: Hematinic I ARF: Iron

Iron is transported in the plasma bound to transferrin Transferrin-iron complex receptor-mediated

endocytosis enters maturing erythroid cells Endosomes: ferric ferrous transported by DMT1

hemoglobin synthesis or stored as ferritin. The transferrin-transferrin receptor complex is recycled

to the plasma membrane, where the transferrin dissociates and returns to the plasma.

Page 23: Hematinic I ARF: Iron

Storage : in intestinal mucosal cells: as ferritin in macrophages in the liver, spleen, and bone, and in

parenchymal liver cells. Apoferritin synthesis is regulated by the levels of

free iron. Ferritin present in serum is in equilibrium with

storage ferritin in reticuloendothelial tissues the serum ferritin level can be used to estimate total body iron stores.

Page 24: Hematinic I ARF: Iron

no mechanism for excretion Small amounts are lost in the feces by :

exfoliation of intestinal mucosal cells trace amounts are excreted in bile, urine, and

sweat no more than 1 mg of iron per day.

regulation of iron balance : absorption and storage

Page 25: Hematinic I ARF: Iron

http://izzrawda.wordpress.com/2009/03/16/do-you-have-anemia/

Page 26: Hematinic I ARF: Iron

The daily requirement of iron Male : 1mg / day Female

▪ 2mg / day▪ 3mg / day (during pregnancy and lactation)

Iron deficiency anaemia can occur under the following four conditions: Less Intake of Fe, Vitamins and Protein Diminished Absorption Increased Loss Excessive Demand

Page 27: Hematinic I ARF: Iron
Page 28: Hematinic I ARF: Iron

Basically: Iron deficiency Application:

Iron deficiency due to dietary lack or to chronic blood loss.

Pregnancy: TM2 GIT abnormality: malabsorption Premature baby Early treatment of pernicious anemia

Page 29: Hematinic I ARF: Iron

Oral: ferrous sulfate, ferrous succinate, ferrous gluconate and

ferrous fumarate. SE: GIT upset, blackened stool, teeth stain Form: tablet, liquid, sustained-release

Parenteral iron Indication: not able to absorb oral iron Prep

Deep IM: iron-dextran (50 mg Fe/mL) or iron-sorbitol precaution: local reaction, anaphylaxis

Slow IV: iron dextran, sodium ferric gluconate complex, iron sucrose Precaution: risk of anaphylacsis!!!

Oral iron should not be given 24 h before i.m. begin and for 5 days after the last i.v. injection;

Page 30: Hematinic I ARF: Iron
Page 31: Hematinic I ARF: Iron

Therapeutic dose: 3-6 mg/Kg/day of elemental ironInduces an ↑Hb of

0.25-0.4 g/dl per day or 1%/day rise in hematocrit. Adequate response:

↑ Hb of 2 g/dl after 3 weeks of tx Failure of response

after 2 weeks of oral iron requires reevaluation for ongoing blood losses,infection,poor compliance or other causes of microcytic anaemia.

Priority: oral preparation.

Page 32: Hematinic I ARF: Iron

Iron chelates in the gut with tetracyclines, penicillamine, methyldopa, levodopa, carbidopa, ciprofloxacin, norfloxacin and ofloxacin;

it also forms stable complexes with thyroxine, captopril and biphosphonates.

Ingestion should be separated by 3 hours. ↑absorption: vit C ↓absorption: desferrioxamine, tea (tannins) ,

Ca, Zn, and bran

Page 33: Hematinic I ARF: Iron

chronic infection in haemolytic anaemias unless there is also

haemoglobinuria increased erythropoiesis associated with chronic

haemolytic states stimulates increased iron absorption and adding to the iron load may cause haemosiderosis.

Page 34: Hematinic I ARF: Iron

Dose related, include nausea, abdominal cramps and diarrhoea. overcome : ↓dose or by taking the tablets after or with meals

Acute iron toxicity Ingestion of large quantities of iron salts. Result: severe necrotising gastritis with vomiting,

haemorrhage and diarrhoea collapse Treatment : gastric lavage with NaHCO3, iron chelating

agent, and treatment of causes. Chronic iron toxicity

Caused by conditions other than ingestion of iron salts, Cause pancreatic damage and leading to diabetes.

Page 35: Hematinic I ARF: Iron
Page 36: Hematinic I ARF: Iron
Page 37: Hematinic I ARF: Iron

Used for treatment of iron toxicity Desferrioxamine(Desferal) (t1/2 6 h).

▪ not absorbed from the gut but is nonetheless given intragastrically following acute overdose (to bind iron in the bowel lumen and prevent its absorption) as well as IM and IV

▪ In severe poisoning: slow IV too fast: hypotension▪ forms a complex with ferric iron, excreted in the urine.

Deferiprone ▪ orally absorbed ▪ to treat iron overload in patients with thalassaemia major, in

whom desferrioxamine is CI. ▪ careful monitoring : Agranulocytosis and other blood

dsyscrasias

Page 38: Hematinic I ARF: Iron

Present as haemoglobin; myoglobin, cytochromes and other enzymes. Absorption: Ferric iron (Fe 3+) ferrous iron (Fe 2+)

active transport into mucosal cells in jejunum and upper ileum transported into plasma and/or stored intracellularly as ferritin.

Iron loss occurs mainly by sloughing of ferritin-containing mucosal cells; iron is not excreted in the urine.

Iron in plasma is bound to transferrin, and most is used for erythropoiesis. Some is stored as ferritin in other tissues. Iron from time-expired erythrocytes enters the plasma for re-use.

The main therapeutic preparation is ferrous sulfate. Unwanted effects include gastrointestinal disturbances. Severe toxic effects

occur if large doses are ingested; these can be countered by desferrioxamine, an iron chelator.

Page 39: Hematinic I ARF: Iron
Page 40: Hematinic I ARF: Iron

Basic and Clinical Pharmacology 11th Ed, Katzung

Pharmacology Rang et al 5th Edition Goodman & Gilman’s The Pharmacological

Basis of Therapeutics, 11th ed. Color atlas of pharmacology Clinical Pharmacology, 9th Ed USMLE Pharmacology Recall Pharmacology for the health care profession

Page 41: Hematinic I ARF: Iron